Literature DB >> 5834735

Experimental evaluation of potential anticancer agents. XIX. Sensitivity of nondividing leukemic cell populations to certain classes of drugs in vivo.

F M Schabel, H E Skipper, M W Trader, W S Wilcox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5834735

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  10 in total

Review 1.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  The mode of action of cytotoxic drugs.

Authors:  M C Berenbaum
Journal:  Proc R Soc Med       Date:  1970-10

3.  Cell proliferation in human melanoma.

Authors:  S Shirakawa; J K Luce; I Tannock; E Frei
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

4.  Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.

Authors:  S Fujimoto; Y Wang; M Ogawa
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Development of an in vitro colony formation assay for the evaluation of in vivo chemotherapy of a rat brain tumor.

Authors:  M L Rosenblum; K D Knebel; K T Wheeler; M Barker; C B Wilson
Journal:  In Vitro       Date:  1975 Sep-Oct

6.  Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.

Authors:  L J Wilkoff; D A Dulmadge; W R Laster; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).

Authors:  L J Wilkoff; E A Dulmadge; M W Trader; S D Harrison; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Non-cytotoxic activity of pyran copolymer-induced macrophages associated with potentiation of tumour vaccine in recipient mice.

Authors:  T Kataoka; F Oh-hashi
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 9.  Some aspects of size-dependent differential drug response in primary and metastatic tumors.

Authors:  I Abe; M Suzuki; K Hori; S Saito; H Sato
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

10.  PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.

Authors:  Ingrid M Ariës; Kimberly Bodaar; Salmaan A Karim; Triona Ni Chonghaile; Laura Hinze; Melissa A Burns; Maren Pfirrmann; James Degar; Jack T Landrigan; Sebastian Balbach; Sofie Peirs; Björn Menten; Randi Isenhart; Kristen E Stevenson; Donna S Neuberg; Meenakshi Devidas; Mignon L Loh; Stephen P Hunger; David T Teachey; Karen R Rabin; Stuart S Winter; Kimberly P Dunsmore; Brent L Wood; Lewis B Silverman; Stephen E Sallan; Pieter Van Vlierberghe; Stuart H Orkin; Birgit Knoechel; Anthony G Letai; Alejandro Gutierrez
Journal:  J Exp Med       Date:  2018-11-07       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.